X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (3) 3
hematology, oncology and palliative medicine (3) 3
index medicus (3) 3
aged (2) 2
dosage and administration (2) 2
drug therapy (2) 2
efficacy (2) 2
female (2) 2
humans (2) 2
male (2) 2
middle aged (2) 2
myelofibrosis (2) 2
myeloproliferative neoplasms (2) 2
primary myelofibrosis - drug therapy (2) 2
protein kinase inhibitors - therapeutic use (2) 2
safety (2) 2
[sdv.can]life sciences [q-bio]/cancer (1) 1
advanced basic science (1) 1
analysis (1) 1
anemia - complications (1) 1
animals (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
arthritis (1) 1
association (1) 1
available therapy (1) 1
breast-cancer (1) 1
bridged-ring compounds - administration & dosage (1) 1
bridged-ring compounds - adverse effects (1) 1
bridged-ring compounds - pharmacology (1) 1
cancer (1) 1
cancer susceptibility gene (1) 1
care and treatment (1) 1
cyt387 (1) 1
disease-free survival (1) 1
dog diseases - genetics (1) 1
dogs (1) 1
erythrocytosis (1) 1
essential thrombocythemia (1) 1
exon-12 (1) 1
exons (1) 1
expression (1) 1
fms-like tyrosine kinase 3 - drug effects (1) 1
follow-up studies (1) 1
germline (1) 1
hepatocyte growth-factor (1) 1
inhibitor (1) 1
jak1 (1) 1
janus kinase 2 - antagonists & inhibitors (1) 1
janus kinase 2 - drug effects (1) 1
janus kinase 2 - genetics (1) 1
life sciences (1) 1
macrocycles (1) 1
magnetic resonance imaging (1) 1
management (1) 1
maximum tolerated dose (1) 1
medicine, research & experimental (1) 1
mice (1) 1
mutation (1) 1
myeloproliferative disorders (1) 1
oncology (1) 1
pancytopenia - complications (1) 1
pathway (1) 1
polycythemia - genetics (1) 1
polycythemia - veterinary (1) 1
polycythemia-vera (1) 1
primary myelofibrosis - complications (1) 1
primary myelofibrosis - epidemiology (1) 1
protein kinase inhibitors - adverse effects (1) 1
pyrazoles - adverse effects (1) 1
pyrazoles - therapeutic use (1) 1
pyrimidines - administration & dosage (1) 1
pyrimidines - adverse effects (1) 1
pyrimidines - pharmacology (1) 1
pyrrolidines - therapeutic use (1) 1
revision (1) 1
risk (1) 1
ruxolitinib (1) 1
somatic mutations (1) 1
spleen - diagnostic imaging (1) 1
spleen - drug effects (1) 1
sulfonamides - therapeutic use (1) 1
thrombocytopenia - complications (1) 1
tomography, x-ray computed (1) 1
treatment failure (1) 1
treatment outcome (1) 1
tyrosine kinase jak2 (1) 1
usage (1) 1
v617f (1) 1
variants (1) 1
vera (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Haematology, The, ISSN 2352-3026, 2017, Volume 4, Issue 5, pp. e225 - e236
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 07/2019, Volume 25, Issue 14, pp. 4504 - 4515
Purpose: The genesis of all cancers results from an accumulation of mutations, constitutional and/or acquired when induced by external mutagenic factors.... 
BREAST-CANCER | POLYCYTHEMIA-VERA | GERMLINE | VARIANTS | ONCOLOGY | HEPATOCYTE GROWTH-FACTOR | RISK | CANCER SUSCEPTIBILITY GENE | ARTHRITIS | ASSOCIATION | SOMATIC MUTATIONS | Life Sciences | Cancer
Journal Article
Experimental Hematology, ISSN 0301-472X, 2011, Volume 39, Issue 5, pp. 542 - 545
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.